Next Article in Journal / Special Issue
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols
Previous Article in Journal / Special Issue
Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
Article Menu

Export Article

Open AccessReview
Toxins 2017, 9(1), 26; doi:10.3390/toxins9010026

The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin

1
First Division of Nephrology, Department of Cardio-thoracic and Respiratory Sciences, University of Campania “Luigi Vanvitelli”, School of Medicine, via Pansini 5, Bldg 17, Naples 80131, Italy
2
Department of Biochemistry, Biophysics and General Pathology, University of Campania “Luigi Vanvitelli”, School of Medicine, via Luigi de Crecchio 7, Naples 80138, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: R. Vanholder
Received: 26 October 2016 / Revised: 28 December 2016 / Accepted: 2 January 2017 / Published: 10 January 2017
(This article belongs to the Special Issue Novel Issues in Uremic Toxicity)
View Full-Text   |   Download PDF [1476 KB, uploaded 10 January 2017]   |  

Abstract

Lanthionine is a nonproteinogenic amino acid, composed of two alanine residues that are crosslinked on their β-carbon atoms by a thioether linkage. It is biosynthesized from the condensation of two cysteine molecules, while the related compound homolanthionine is formed from the condensation of two homocysteine molecules. The reactions can be carried out by either cystathionine-β-synthase (CBS) or cystathionine-γ-lyase (CSE) independently, in the alternate reactions of the transsulfuration pathway devoted to hydrogen sulfide biosynthesis. Low plasma total hydrogen sulfide levels, probably due to reduced CSE expression, are present in uremia, while homolanthionine and lanthionine accumulate in blood, the latter several fold. Uremic patients display a derangement of sulfur amino acid metabolism with a high prevalence of hyperhomocysteinemia. Uremia is associated with a high cardiovascular mortality, the causes of which are still not completely explained, but are related to uremic toxicity, due to the accumulation of retention products. Lanthionine inhibits hydrogen sulfide production in hepatoma cells, possibly through CBS inhibition, thus providing some basis for the biochemical mechanism, which may significantly contribute to alterations of metabolism sulfur compounds in these subjects (e.g., high homocysteine and low hydrogen sulfide). We therefore suggest that lanthionine is a novel uremic toxin. View Full-Text
Keywords: lanthionine; homolanthionine; hydrogen sulfide; homocysteine; hemodialysis; uremic toxins lanthionine; homolanthionine; hydrogen sulfide; homocysteine; hemodialysis; uremic toxins
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Perna, A.F.; Zacchia, M.; Trepiccione, F.; Ingrosso, D. The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin. Toxins 2017, 9, 26.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top